药品注册申请号:012380
申请类型:NDA (新药申请)
申请人:PARKE DAVIS
申请人全名:PARKE DAVIS DIV WARNER LAMBERT CO
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 ZARONTIN ETHOSUXIMIDE CAPSULE;ORAL 250MG Yes Yes AB 1960/11/02 Approved Prior to Jan 1, 1982 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2021/10/28 SUPPL-37(补充) Approval Labeling STANDARD
2016/05/17 SUPPL-36(补充) Approval Labeling STANDARD
2012/05/03 SUPPL-34(补充) Approval Labeling UNKNOWN
2011/06/15 SUPPL-33(补充) Approval REMS N/A
2010/09/14 SUPPL-32(补充) Approval Labeling STANDARD
2009/04/23 SUPPL-31(补充) Approval Labeling 901 REQUIRED
2006/09/01 SUPPL-30(补充) Approval Labeling STANDARD
2002/04/19 SUPPL-29(补充) Approval Labeling STANDARD
2001/04/09 SUPPL-25(补充) Approval Labeling STANDARD
2001/04/09 SUPPL-23(补充) Approval Labeling
2001/04/09 SUPPL-22(补充) Approval Labeling
2000/09/22 SUPPL-28(补充) Approval Manufacturing (CMC) PRIORITY
2000/06/28 SUPPL-27(补充) Approval Manufacturing (CMC) PRIORITY
1996/02/22 SUPPL-24(补充) Approval Manufacturing (CMC) PRIORITY
1991/01/08 SUPPL-21(补充) Approval Manufacturing (CMC) PRIORITY
1984/07/31 SUPPL-20(补充) Approval Manufacturing (CMC) PRIORITY
1983/11/08 SUPPL-19(补充) Approval Manufacturing (CMC) PRIORITY
1982/09/03 SUPPL-18(补充) Approval Manufacturing (CMC) PRIORITY
1981/12/09 SUPPL-17(补充) Approval Manufacturing (CMC) PRIORITY
1981/05/28 SUPPL-16(补充) Approval Manufacturing (CMC) PRIORITY
1981/05/28 SUPPL-15(补充) Approval Manufacturing (CMC) PRIORITY
1981/02/03 SUPPL-14(补充) Approval Manufacturing (CMC) PRIORITY
1980/12/11 SUPPL-12(补充) Approval Manufacturing (CMC) PRIORITY
1980/06/02 SUPPL-11(补充) Approval Manufacturing (CMC) PRIORITY
1960/11/02 ORIG-1(原始申请) Approval Type 1 - New Molecular Entity PRIORITY
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:ETHOSUXIMIDE 剂型/给药途径:CAPSULE;ORAL 规格:250MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
012380 001 NDA ZARONTIN ETHOSUXIMIDE CAPSULE;ORAL 250MG Prescription Yes Yes AB Approved Prior to Jan 1, 1982 PARKE DAVIS
040430 001 ANDA ETHOSUXIMIDE ETHOSUXIMIDE CAPSULE;ORAL 250MG Prescription No No AB 2002/10/28 BIONPHARMA
040686 001 ANDA ETHOSUXIMIDE ETHOSUXIMIDE CAPSULE;ORAL 250MG Prescription No No AB 2008/05/28 EPIC PHARMA LLC
200892 001 ANDA ETHOSUXIMIDE ETHOSUXIMIDE CAPSULE;ORAL 250MG Prescription No No AB 2012/09/25 HERITAGE PHARMS INC
211928 001 ANDA ETHOSUXIMIDE ETHOSUXIMIDE CAPSULE;ORAL 250MG Prescription No No AB 2019/02/19 STRIDES SOFTGELS
210654 001 ANDA ETHOSUXIMIDE ETHOSUXIMIDE CAPSULE;ORAL 250MG Prescription No No AB 2020/03/16 PURACAP PHARM LLC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database